LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LondonWallet
No Result
View All Result

Cannabis stocks rally on Wall Street Journal report that Trump is weighing drug reclassification

Chaim Potok by Chaim Potok
August 11, 2025
in Investing
Cannabis stocks rally on Wall Street Journal report that Trump is weighing drug reclassification
74
SHARES
1.2k
VIEWS
Share on FacebookShare on Twitter


A worker inspects cannabis plants inside the grow room at the Aphria Inc. Diamond facility in Leamington, Ontario, Canada, on Wednesday, Jan. 13, 2021. Tilray Inc. and Aphria Inc. agreed to combine their operations, forming a new giant in the fast-growing cannabis industry.

Annie Sakkab | Bloomberg | Getty Images

Stock Chart IconStock chart icon

Cannabis ETFs, 1-day

Many stocks in the sector now sell for less than a dollar per share, meaning a move of just a few cents can lead to a large percentage change. Despite Monday’s rally, many of these stocks are far below their all-time highs.

The latest gains followed a report in the Wall Street Journal late Friday, citing people familiar with White House thinking, that Trump was weighing whether to move marijuana to a less-dangerous drug classification. Trump shared his consideration of the matter during a fundraiser at his New Jersey golf club earlier this month, the people said.

Under federal law, cannabis is currently classified as a Schedule I drug in a group that also includes heroin and cocaine. Previously, reclassification discussions have centered on moving the drug to Schedule III, a class that includes steroids and Tylenol with codeine.

Reclassification would allow marijuana companies to fall under different tax regulations and encourage investment interest, among other benefits.

A move from Schedule 1 to Schedule 3 would be “a gamechanger” for the roughly $80 billion market, said Tim Seymour, investing chief at Seymour Asset Management, on CNBC’s “Worldwide Exchange” on Monday. He noted that such a change has seemingly bipartisan support.

“It does not mean that it won’t be a complicated trade,” Seymour said. “But it does mean that you’re investing now well ahead of a lot of institutional capital if you are, in fact, investing into this sector.”

To be sure, Trump’s backing can brighten the outlook but he cannot reclassify the drug alone. The Controlled Substances Act places that authority under the Attorney General, who has historically delegated it further the administrator of the Drug Enforcement Administration.



Source link

You might also like

Tuesday’s big stock stories: What’s likely to move the market in the next trading session

Million-dollar earners have already stopped paying into Social Security for 2026

Oil was last above $100 back in 2022. These were the best and worst stocks to own during that stretch

Share30Tweet19
Previous Post

Betting on a bullish earnings move in Cisco Systems using options

Next Post

Crypto helps emerging economies bypass legacy financial constraints

Chaim Potok

Chaim Potok

Recommended For You

Tuesday’s big stock stories: What’s likely to move the market in the next trading session
Investing

Tuesday’s big stock stories: What’s likely to move the market in the next trading session

March 9, 2026
Million-dollar earners have already stopped paying into Social Security for 2026
Investing

Million-dollar earners have already stopped paying into Social Security for 2026

March 9, 2026
Oil was last above 0 back in 2022. These were the best and worst stocks to own during that stretch
Investing

Oil was last above $100 back in 2022. These were the best and worst stocks to own during that stretch

March 9, 2026
Higher energy prices mean this stock’s big dividend will get even larger. Investor Harrington is a buyer
Investing

Higher energy prices mean this stock’s big dividend will get even larger. Investor Harrington is a buyer

March 9, 2026
Next Post
Crypto helps emerging economies bypass legacy financial constraints

Crypto helps emerging economies bypass legacy financial constraints

Related News

Bitcoin ’tick tock’ fractal predicts 0K BTC price top in October

Bitcoin ’tick tock’ fractal predicts $150K BTC price top in October

July 31, 2025
Crypto.com gets EU nod on MiCA license

Crypto.com gets EU nod on MiCA license

January 17, 2025
Industry boss: US actors strike may cause little if any disruption to UK cinemas

Industry boss: US actors strike may cause little if any disruption to UK cinemas

July 14, 2023

Browse by Category

  • Business Finance
  • Crypto
  • Industries
  • Investing
  • Markets
  • Opinion
  • Real Estate
  • UK

London Wallet

Read latest news about finance, business and investing

  • Contact
  • Privacy Policy
  • Terms & Conditions

© 2025 London Wallet - All Rights Reserved!

No Result
View All Result
  • Checkout
  • Contact
  • Home
  • Login/Register
  • My account
  • Privacy Policy
  • Terms and Conditions

© 2025 London Wallet - All Rights Reserved!

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?